Celyad Stock Today

CYAD
 Stock
  

USD 1.07  0.05  4.90%   

Market Performance
0 of 100
Odds Of Distress
Less than 7
Celyad Sa is trading at 1.07 as of the 26th of November 2022, a 4.90 percent up since the beginning of the trading day. The stock's lowest day price was 1.03. Celyad Sa has only a 7 % chance of going through financial distress over the next few years, but has generated negative returns over the last 90 days. Equity ratings for Celyad Sa ADR are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 6th of December 2020 and ending today, the 26th of November 2022. Click here to learn more.
CUSIP
151205200
Fiscal Year End
December
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
IPO Date
19th of June 2015
Category
Healthcare
Classification
Health Care
Celyad Oncology SA, a clinical-stage biopharmaceutical company, focuses on the discovery and development of chimeric antigen receptor T cell therapies for the treatment of cancer. Celyad Oncology SA was founded in 2004 and is headquartered in Mont-Saint-Guibert, Belgium. The company has 22.59 M outstanding shares of which 161.84 K shares are currently shorted by private and institutional investors with about 25.21 trading days to cover. More on Celyad Sa ADR

Moving against Celyad Sa

-0.83SGMLSigma Lithium Corp Sell-off TrendPairCorr
-0.52TWTRTwitter DelistingPairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Celyad Sa Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Celyad Sa's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Celyad Sa or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Celyad Sa ADR generated a negative expected return over the last 90 days
Celyad Sa ADR has some characteristics of a very speculative penny stock
Celyad Sa ADR has high historical volatility and very poor performance
The company reported the previous year's revenue of 5 K. Net Loss for the year was (25.71 M) with profit before overhead, payroll, taxes, and interest of 5 K.
Celyad Sa ADR currently holds about 14.38 M in cash with (30.77 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.64.
CEOChristian Homsy
Average Analyst Recommendation
Analysts covering Celyad Sa report their recommendations after researching Celyad Sa's financial statements, talking to executives and customers, or listening in on Celyad Sa's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Celyad Sa ADR. The Celyad consensus assessment is calculated by taking the average forecast from all of the analysts covering Celyad Sa.
Strong Buy3 Opinions
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Celyad Sa's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Celyad Sa ADR (CYAD) is traded on NASDAQ Exchange in USA and employs 95 people. The company currently falls under 'Micro-Cap' category with current market capitalization of 24.8 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Celyad Sa's market, we take the total number of its shares issued and multiply it by Celyad Sa's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Celyad Sa ADR conducts business under Healthcare sector and is part of Biotechnology industry. The entity has 22.59 M outstanding shares of which 161.84 K shares are currently shorted by private and institutional investors with about 25.21 trading days to cover. Celyad Sa ADR currently holds about 14.38 M in cash with (30.77 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.64.
Check Celyad Sa Probability Of Bankruptcy
Ownership
Celyad Sa holds a total of twenty-two million five hundred ninety thousand outstanding shares. Almost 71.0 percent of Celyad Sa outstanding shares are held by regular investors with 0.05 (percent) owned by insiders and only 29.14 % by other corporate entities. Please note that no matter how much assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Ownership Allocation (%)

Check Celyad Ownership Details

Celyad Stock Price Odds Analysis

What are Celyad Sa's target price odds to finish over the current price? Based on a normal probability distribution, the odds of Celyad Sa jumping above the current price in 90 days from now is about 79.13%. The Celyad Sa ADR probability density function shows the probability of Celyad Sa stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days Celyad Sa has a beta of 0.2994 suggesting as returns on the market go up, Celyad Sa average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Celyad Sa ADR will be expected to be much smaller as well. Additionally, the company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Celyad Sa ADR is significantly underperforming DOW.
  Odds Below 1.07HorizonTargetOdds Above 1.07
20.82%90 days
 1.07 
79.13%
Based on a normal probability distribution, the odds of Celyad Sa to move above the current price in 90 days from now is about 79.13 (This Celyad Sa ADR probability density function shows the probability of Celyad Stock to fall within a particular range of prices over 90 days) .

Celyad Stock Institutional Holders

Institutional Holdings refers to the ownership stake in Celyad Sa that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Celyad Sa's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Celyad Sa's value.
InstituionSecurity TypeTotal SharesValue
Zurcher Kantonalbank Zurich CantonalbankCommon Shares100.01000
Zurcher Kantonalbank Zurich CantonalbankCommon Shares100.01000
View Celyad Sa Diagnostics

Celyad Sa ADR Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Celyad Sa market risk premium is the additional return an investor will receive from holding Celyad Sa long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Celyad Sa. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Celyad Sa's alpha and beta are two of the key measurements used to evaluate Celyad Sa's performance over the market, the standard measures of volatility play an important role as well.

Celyad Stock Against Markets

Picking the right benchmark for Celyad Sa stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Celyad Sa stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Celyad Sa is critical whether you are bullish or bearish towards Celyad Sa ADR at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Celyad Sa without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Equity Analysis Now

   

Equity Analysis

Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
All  Next Launch Module

Celyad Sa Corporate Directors

Celyad Sa corporate directors refer to members of a Celyad Sa board of directors. The board of directors generally takes responsibility for the Celyad Sa's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Celyad Sa's board members must vote for the resolution. The Celyad Sa board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
JeanMarc Heynderickx - Independent DirectorProfile
Serge Goblet - Non-Executive DirectorProfile
Louise Proulx - Independent DirectorProfile
Chris Buyse - Independent Director, permanent representative of Life Sciences Research PartnersProfile

Invested in Celyad Sa ADR?

The danger of trading Celyad Sa ADR is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Celyad Sa is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Celyad Sa. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Celyad Sa ADR is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Continue to Trending Equities. Note that the Celyad Sa ADR information on this page should be used as a complementary analysis to other Celyad Sa's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Complementary Tools for Celyad Stock analysis

When running Celyad Sa ADR price analysis, check to measure Celyad Sa's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celyad Sa is operating at the current time. Most of Celyad Sa's value examination focuses on studying past and present price action to predict the probability of Celyad Sa's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Celyad Sa's price. Additionally, you may evaluate how the addition of Celyad Sa to your portfolios can decrease your overall portfolio volatility.
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Is Celyad Sa's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Celyad Sa. If investors know Celyad will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Celyad Sa listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
24.2 M
Quarterly Revenue Growth YOY
(1.00) 
Return On Assets
(0.29) 
Return On Equity
(0.93) 
The market value of Celyad Sa ADR is measured differently than its book value, which is the value of Celyad that is recorded on the company's balance sheet. Investors also form their own opinion of Celyad Sa's value that differs from its market value or its book value, called intrinsic value, which is Celyad Sa's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Celyad Sa's market value can be influenced by many factors that don't directly affect Celyad Sa's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Celyad Sa's value and its price as these two are different measures arrived at by different means. Investors typically determine Celyad Sa value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Celyad Sa's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.